Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Overview | Financials
Company Name Black Diamond Therapeutics, Inc.
Symbol BDTX
Currency USD
Price 4.73
Market Cap 267,268,177
Dividend Yield 0%
52-week-range 1.62 - 7.66
Industry Biotechnology
Sector Healthcare
CEO Dr. Mark A. Velleca M.D., Ph.D.
Website https://www.blackdiamondtherapeutics.com

An error occurred while fetching data.

About Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver

Related Stocks

Molecular Templates, Inc. logo

Molecular Templates, Inc.

MTEM

1.34 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.04 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

25.5 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.675 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.32 USD

Purple Biotech Ltd. logo

Purple Biotech Ltd.

PPBT

7.1 USD

Solid Biosciences Inc. logo

Solid Biosciences Inc.

SLDB

7.14 USD

Financials

Numbers are in millions USD

Numbers are in millions USD